We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Phreesia Inc (PHR) USD0.01

Sell:$54.21 Buy:$54.26 Change: $1.83 (3.26%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Change: $1.83 (3.26%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Change: $1.83 (3.26%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Phreesia, Inc. is a provider of software solutions. The Company provides healthcare organizations a suite of applications to manage the patient intake process and payment solutions for patient payments. It has developed its software as a service (SaaS)-based technology platform with a focus on delivering reliability, performance, security and privacy. The Company’s SaaS platform operates as a single, unified, multi-tenant platform that has demonstrated scalability and seamless integration within the operating infrastructure of its provider clients. The Company’s platform offers various solutions to its clients, Which includes appointments, registration, revenue cycle, clinical support, COVID-19 product offerings, patient activation and life sciences solutions. It serves an array of provider clients ranging from single-specialty practices, which include internal and family medicine, urology, dermatology, and orthopedics to multi-specialty groups and health systems.

Contact details

United States
+1 (646) 7479959

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$2.76 billion
Shares in issue:
50.88 million
Health Care Technology
New York Stock Exchange
United States
US dollar

Key personnel

  • Chaim Indig
    Chief Executive Officer, Director
  • Randy Rasmussen
    Chief Financial Officer
  • Evan Roberts
    Chief Operating Officer
  • Michael Davidoff
    Senior Vice President - Marketing and Business Development
  • Amy VanDuyn
    Senior Vice President - Human Resources
  • Balaji Gandhi
    Senior Vice President - Investor Relations
  • David Linetsky
    Senior Vice President - Life Sciences
  • Daniel Nathan
    Chief Technology Officer
  • Allison Hoffman
    General Counsel, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.